Renewal of Early Access to Medicines Scheme for idebenone for patients with deteriorating respiratory function by MHRA

An announcement was made by the Santhera Pharmaceuticals that the Medicines & Healthcare products Regulatory Agency of the United Kingdom has renewed the Early Access to Medicines Scheme for another year for idebenone for those patients who have Duchenne muscular…